CONTENTS
02 About the Report Social
03 Statement of the Board of Directors
04 Message from the Chairman 02
06 Performance Highlights in 2024 45 Product Responsibility
34 Innovation Empowerment 45 Quality Management
Scientific Research Framework 47 Customer Service34
35 R&D investment 48 Sustainable Supply Chain
08 About Us 35 Recently Introduced Products 49 Employee Development
16 Sustainability Management 37 Intellectual Property Protection
08 Business Layout 49 Employees Rights and Interests
16 ESG Strategic Planning 37 Experimental Ethics
10 Corporate Cultures 51 Cultivation and Development
16 ESG Management System
11 Development trategys 38 Collaborative Industry Advancement 55 Welfare and Care
17 Stakeholders' Communication
12 Development History
Materiality Assessment 38 Academic Exchange
58 Occupational Health and Safety
17
14 Awards and Recognitions 40 Standard Establishment 60 Serve The Society
41 School-Enterprise Cooperation
60 International Aid Initiatives
42 Training and Talent Cultivation
61 Medical Donation
44 Accessibility of Medical Services
62 Public Welfare and Charity
64 Scientific Popularization
01Environmental
Governance
20 Environmental Management
73 Risk Management and Control
20 Environmental Management System 27 Resource Management 03
21 Environmental Risk Management Water Resource Management 68 Corporate Governance 73 Compliance and Internal Control Management27
Energy Management 73 Related Party Transactions and Control22 Pollution Prevention 28 68 Governance Structure
74 Analysis of Public Opinion
22 Waste Water Management 29 Green Production 69 Board Operation
30 Green Office Practices 74 Anti-Fraud and Anti-Corruption Measures
23 Waste Gas Management 70 Information Disclosure 75 Anti-Competitive Practices
24 Waste Management 31 Climate Action 70 Investor Relations Management 75 Reporting Mechanism
26 Noise Management 72 Investor Returns 75 Information Security
72 Market Capitalization Management
76 Appendix2024 Environmental Social and Governance Report
About the Report Statement of the Board of Directors
Report Overview
Eyebright Medical Technology (Beijing) Co. Ltd. (hereinafter referred to as "Eyebright Medical" "the Company"
or "we") has systematically established an ESG management framework to achieve an in-depth integration of
shareholder rights protection and sustainable corporate development.Report Scope
The Board of Directors of Eyebright Medical assume
The scope of this report encompasses Eyebright Medical and its affiliated subsidiaries. overall responsibility for the accuracy completeness and
timeliness of the content and information disclosed in this
Reporting Period report. As the core decision-making body of corporate
This report covers the period from January 1 2024 to December 31 2024. governance the Board is fully and deeply responsible
for matters related to Environmental (E) Social (S) and
Information Sources Governance (G).The data used in this report is sourced from public data released. Unless otherwise noted all non-financial data In the formulation of the ESG governance strategy the
for 2024 is drawn from the Company’s headquarters. The Company assures that the content of this report does Board has developed an ESG strategic roadmap aligned
not contain any false records misleading statements or material omissions. with the Company’s long term objectives. When assessing
ESG-related impacts risks and opportunities the Board
Important Notice employs a rigorous and professional approach helping
identify risks early and seize opportunities ensuring a
This report has been reviewed and approved by the Company's Board of Directors for public disclosure. The solid foundation for the Company's stable development.Company and the board of directors assure that the content of this report does not contain any false records
misleading statements or material omissions. The board of directors has established a comprehensive
oversight mechanism closely monitoring the progress of
Basis for Compilation various ESG initiatives to ensure that strategic decisions
The Global Sustainability Standards Board - "Global Reporting Initiative" can be effectively implemented. At the same time the
board continuously tracks the progress of ESG-related
China Enterprise Reform and Development Research Association - "China Enterprise Sustainable Development goals and adjusts strategies and action plans in a timely
Report Guidelines (CASS-ESG 6.0)" manner based on actual conditions ensuring that the
National Standard of China - "Guidelines for the Preparation of Social Responsibility Reports" (GB/T36001-2015) Company continues to make positive progress in the ESG
field.International Organization for Standardization - "ISO 26000: Guidance on Social Responsibility" (2010)
Shanghai Stock Exchange - "Self-Regulatory Guidelines No. 1 for Listed Companies on the Sci-Tech Innovation The Company's board of directors places great importance
Board: Standard Operations" on information disclosure. Each year the board conducts
a rigorous review of the Company's ESG report to
Guidelines No. 14 of Shanghai Stock Exchange for Self-Regulation of Listed Companies- Sustainable ensure that the report accurately and truthfully reflects
Development Reports (Trial) the Company's the effectiveness and reliability of the
Guidelines No. 13 of Shanghai Stock Exchange for Self-Regulation of Listed Companies on the Sci-Tech Company's ESG efforts.Innovation Board - Preparation of Sustainable Development Reports
This report provides a detailed disclosure of Eyebright
United Nations - "Guidelines for Corporate Action on the Sustainable Development Goals (SDGs)" Medical's progress and achievements in ESG work for
2024 having been reviewed and approved at the meeting
Access Information of the Board of Directors.The electronic version of the Report is available for downloading from the Eyebright Medical official
website(www.ebmedical.com) and the Shanghai Stock Exchange website (www.sse.com.cn).For any questions or suggestions regarding the report please contact us via: investors@ebmedical.com or
（86）10-89748322. In case of any discrepancy or inconsistency in the versions the Chinese version shall prevail.
2 32024 Environmental Social and Governance Report
Message from the Chairman
Twin Growth Engines Ignite a New Journey: Setting Sail for Global Horizons“Dear valued partners and friends from all walks of
cutt ing-edge R&D. The aspher ic d i f f ract ive regions including Henan Qinghai Gansu Shandong
life
multifocal intraocular lens has now been included Xinjiang and Tibet bringing light and hope to those
Warm greetings to everyone! in the National Centralized Procurement Program in need. We also participated in international aid
increasing sales that accelerate domestic substitution projects providing vision care to patients in countries
In 2024 China's healthcare reform maintains to meet high-end consumer demands. In myopia such as Venezuela Equatorial Guinea Uzbekistan
deepening momentum as systemic overhauls — management and control the Company has been Kyrgyzstan Ethiopia Zimbabwe Tajikistan Senegal
spanning centralized medical device procurement continuously refining and upgrading its proprietary and Mauritania.and dynamic reimbursement list updates — establish technologies. Products like orthokeratology lenses
strategic frameworks steering industry evolution. RGP lenses and defocus glasses offer comprehensive Additionally we have made numerous donations
This policy-market synergy drives dual upgrading myopia management solutions. In the consumer to vulnerable groups and conducted ophthalmic
of demand-supply dynamics amid intensifying vision care sector the Company and its subsidiaries education workshops for children youth and
competition across the sector. have harnessed advantages to cutting - edge seniors demonstrating our commitment to corporate
technological innovations in contact lens. They have responsibility.Under the leadership of the Board Eyebright Medical bridged critical domestic gaps in high - end materials
has proactively aligned with China's 'high-quality and advanced manufacturing processes. Moreover Amid fierce market competition Eyebright Medical
development' policy directives maintaining sustained the gradual increase in production capacity has has sustained resilient growth underpinned by
growth through its dual-driven strategy of "Medical reduced operational costs and become a new engine the enduring trust and strategic alignment of its
+ Consumer" and accelerated global expansion for growth. shareholders. As we enter 2025 the Company
initiatives. reaffirms its commitment to long-term value creation
The Company is exploring international channels by through high-quality development and continues
In 2024 the Company achieved an operating establishing a wholly-owned subsidiary in Hong Kong to deepen our focus in the ophthalmic medical field.revenue of RMB 1410.02 million representing a to advance toward becoming a globally influential We aim to reach new heights in advanced medical
year-on-year growth of 48.24% and a three-year ophthalmic enterprise. It is seeking long-term technology provide superior products for patients
CAGR of 55.99%. The net profit excluding non- partnerships with renowned hospitals key opinion and deliver strong performance for our investors. Let
recurring gains and losses was RMB 390.08 million leaders and leading researchers across the world. us work together to create a brighter future!
reflecting a year-on-year increase of 35.08% and a
three-year CAGR of 37.00%. "To be a respected listed company" is a principle I
have always emphasized. Over the past year we
In product innovation Eyebright Medical remains have actively fulfilled our social responsibilities Eyebright Medical Technology (Beijing) Co. Ltd.unwavering in its mission to advance China's high- by donating intraocular lenses viscoelastic and
end ophthalmic medical device sector through surgical instruments for cataract surgeries in various
April 2025
4 52024 Environmental Social and Governance Report
Performance Highlight in 2024
Business Performance Employee Development
Total Employees 2294 | Y-O-Y Growth 10.61%
Percentage of Female Employees 58%
Operating Revenue RMB 1410.02 Million | Y-O-Y Growth 48.24%
Percentage of Female Executives 50%
Net Income Attributable to Shareholders RMB 388.40 Million | Y-O-Y Growth 27.77%
Cash Paid to Employees RMB 338 Million | Y-O-Y Growth 64.78%
Net Income Excluding Non-recurring Items RMB 390.08 Million | Y-O-Y Growth 35.08%
Training Sessions Conducted 179
Total Assets RMB 3496.97 Million
Total Training Duration 28338 Hours
Basic Earnings per Share RMB 2.05
Total Number of Participants in Training 4595
Equity Attributable to Shareholders RMB 2409.50 Million
Employees with Equity Incentives 78
Weighted Average Return on Equity 17.32%
Total Incentivized Shares 206982 Shares
Innovation Empowerment Governance Performace
Research and Development Personnel 293 Total Board and Committee Meetings Held 15
R&D Investment RMB 159 Million Disclosed Regular Reports 4
Patents Applied 41 Disclosed Temporary Announcements 61
Patents Granted 39 Two Consecutive Years of Information Disclosure Rating Grade A
Total Patents Applied 417 Earning Calls Briefings Held 6
Total Authorized and Valid Patents 256 No Insider Trading
Participation in Standard Formulation and Industry Report Compilation 9 No Correction Announcements
Product Quality Community ontributions and Social Recognition
External Audits Conducted 17 times Taxes Paid RMB 163.62 Million
National Supervision Pass Rate 100% Hosted or Participated in Science Popularization and Charity Activities 15
Total Quality and Safety Training Sessions Held Nearly 50 times Total Donations in Goods Nearly RMB 1.43 Million
Total Honors Received Throughout the Year Over 40 Honors
6 72024 Environmental Social and Governance Report
About
Business Layout
Eyebright Medical Technology (Beijing) Co.Ltd. is a national high-tech enterprise and
a national-level specialized and innovative
"little giant" enterprise founded by Dr. Xie
Jiangbing. The Group's headquarter is in the
Zhongguancun Science Park in Beijing with
holding companies established in Shanghai
Suzhou Chengdu Lianyungang Yantai and
Hong Kong. After ten years of high-quality
innovative development the Company was Surgical Treatment Myopia Management Consumer Vision Care
listed on the Sci-Tech Innovation Board of the
Shanghai Stock Exchange in 2020 with the The Company has developed and produced several The Company is the second manufacturer in China Consumer vision care products include transparent
stock name "Eyebright Medical" and stock domestic pioneering and market-leading intraocular to obtain a product registration certificate for contact lens colored contact lens prescription
code: 688050. lenses including over 20 models such as aspheric orthokeratology lens and is also the world's first eyewear lens and contact lens care products.multifocal extended depth of focus (EDOF) toric producer of full-segment aspheric orthokeratology Subsidiaries hold multiple registration certificates
The Company's balanced product portfolio pre-mounted spherical and pre-mounted aspheric lenses. for contact lens colored contact lens and silicone
spans three major areas of the ophthalmic lenses. hydrogel contact lens. Leveraging its research and
field: cataract surgery myopia management The core product for myopia control is the orthokeratology development advantages the Company is developing
as well as consumer vision care. Adhering to its With core technologies in intraocular lenses and lens while other myopia management products include high-end contact lens that offer greater comfort
five proprietary technology platforms balanced complete independent intellectual property rights defocus glasses daily wear rigid contact lenses enhanced safety and additional functionalities.product portfolio the Company has established Eyebright Medical is currently one of the few defocus soft lenses and related care products.a competitive advantage and entry barriers in intraocular lens manufacturers in China that has
China striding into a world-leading medical successfully entered overseas markets.enterprise on behalf of China's "intelligent
manufacturing" power. The Company has launched China's first aspheric
phakic intraocular lens products the Loong Crystal TM
PR challenging the long-standing dominance of the
ICL products in the Chinese and global markets.
8 92024 Environmental Social and Governance Report
Company Culture Development Strategy
Unlock the potential of existing products to solidify
market leadership
Expand the consumer market and
Eyebright Medical is dedicated to explore new channels
providing cutting-edge ophthalmic
techno log ies p roduc t s and
services to ophthalmic patients and
vision care consumers worldwide.Strengthen the Company's
The Company wil l continue to
leading position in R&D within
implement a dual-driven strategy of
the industry
"Healthcare + Consumer" alongside
i n t e r n a t i o n a l d e ve l o pmen t
continually extending its product
portfolio to provide comprehensive
eye health solutions worldwide. Inject new momentum for growth
through investments
Vision
Enhance overseas presence
ILLUMINATE YOUR WORLD
Case Case Case
In 2024 the Proming Continuous In 2024 T ianyan Medic ine In 2024 Eyebright Medical
Vis ion intraocular lens was and Fujian Unicon achieved established a regional base in
Mission [ 图片 ][ 图片 ]i n c l uded i n t he Na t i ona l substantial capacity ramp-up the Hong Kong Science Park
C e n t r a l i z e d P r o c u r e m e n t with the contact lens business marking a critical milestone in
Program enabling nationwide turning profitable. The Company the Company‘s global expansion
Provide World-class adoption through public hospital embraces new business models s t r a t e g y . T h e C o m p a n y
networks thereby meeting the we have established a strategic a l s o a c t i ve l y pa r t i c i pa t ed
Ophthalmic Technologies high-end demands of domestic partnership with Meituan Medical in internat ional ophthalmic
consumers and accelerating the Health and launched the first academic events such as APAO
Products and Services process of domestic substitution. 24 - hour smart contact lens ESCRS and the Hong Kong
store in Beijing setting a new Sc ience Park Internat iona l
benchmark for retail innovation Registration Symposium.Core Values in vision care.Innovative and Enterprising
Openness and Harmonious
Honesty
Sharing Success
10 112024 Environmental Social and Governance Report
Development History
2010-20142015-20192020-2025
Early Technology Accumulation Expanding Product Portfolio and Rapid Commercialization Initiation of Public Market Listing and Expansion of Operations
2010201620202023
Company Founded NMPA Approval Granted for our Toric IOL Listed on the Shanghai Stock Controlling interest in Fujian Unicon Optical Co. Ltd.Exchange's STAR Market
2019
2014 Established Eyebright Hong Kong advance Internationalization 2021 Strategy
iBright RGP Contact Lens has received
Launch our first Proming Aspheric NMPA approval Completing the acquisition of Tianyan 2024
IOL (A1-UV) the First Domestically- Medicine the Company enter into the
Manufactured IOL with Independent Domestic Users are Covered by Over 2000 Soft Contact Lens Market Beijing Medical Device R&D Center and Production Base
Intellectual Property Rights Ophthalmology Hospitals Inaugurated
2022
Beijing Future Science City Marketing Center in Operation
Yantai Production facilities has operated
Strategic Cooperation with Meituan Medicine to Launch 24-
Proming Continuous Vision Received hour Smart Stores for Contact Lens
NMPA Approval 2025
China's first aspheric phakic intraocular lens product the
Loong CrystalTM PR Phakic Intraocular Lens has received NMPA
Approval
Established Eyebright Switzerland to deepen international
market presence
12 132024 Environmental Social and Governance Report
Awards and Recognitions
Beijing Headquarter Management Team
Top 30 Value Companies on the STAR
Market Pioneer of the STAR Market Capital Labor Medal
2024 Gold Medal CFO Award Outstanding Secretary of the Board Award at the 15th Tianma AwardsShanghai Stock Exchange Golden Quality
- Corporate Governance Award
Machinery Industry Science and
Technology Award
Top 100 Specialized and Innovative
Enterprises in Beijing 2024 爱博诺德（北京）医疗科技股份有限公司
第93名北京企业联合会北京市企业家协会
爱博诺德（北京）医疗科技股份有限公司二〇二四年十二月
Top 100 Manufacturing Enterprises in
Beijing 2024 第 43 名
爱博诺德（北京）医疗科技股份有限公司
Top 100 High-Precision and High-End 北京企业联合会 北京市企业家协会 第 82 名二〇二四年十二月北京企业联合会北京市企业家协会
Enterprises in Beijing 2024 二〇二四年十二月
New Star Unit in Information Work 2024
7th China Excellence IR Best Disclosure
Award
Holding Subsidiaries
Securities Star ESG New Benchmark
Enterprise Award
Jiangsu Specialized and Innovative Small and Jiangsu Provincial-level Intelligent Manufacturing
Medium-sized Enterprises Workshop
Excellent Practice Case for Cultural Jiangsu Innovative Small and Medium-sized
Construction of Listed Companies 2024 Jiangsu Star Cloud EnterprisesEnterprises
Excellent Practice Case for Board of Excellent Management Award of the Jiangsu Province
Directors of Listed Companies 2024 Jiangsu Suzhou Engineering Research Center Lianyungang CityGanyu District Quality Award
Excellent Practice Case for Board Office of
Listed Companies 2024 Fujian Province Specialized and Innovative Small and Fujian Province Postdoctoral Innovation Practice Base
Medium-sized Enterprises
Excellent Practice Case for 2023 Annual Fujian Province Innovative Small and Medium-sized Third Prize for Excellent Innovative Products from
Report Performance Presentation of Enterprises Industrial Enterprises in Fuzhou Fujian Province
Listed Companies
Fifth Batch of Leading Industrial Teams in Fujian Fujian Province "Gazelle" Innovative Enterprises in
Excellent Practice Case for Sustainable Province the Core Digital Economy Industry
Development of Listed Companies 2024
Shandong Specialized and Innovative Small and
Model Employee Home in Penglai District
TOP 500 New Economy Enterprises 2024 Medium-sized Enterprises
14 152024 Environmental Social and Governance Report
Sustainability Management Stakeholder Communication
Stakeholders Expectations and Demands Response Methods/Communication Channels
Eyebright Medical continues to drive innovation United Nations Sustainable
to advance global ophthalmic health while Development Goals Regulated Corporate Enhance corporate governance and investor relations Governance Sustained involves and use online platforms to promptly
maintaining steadfast dedication to the Shareholders
Value Creation Information address investor inquiries. Deliver consistent
harmonious integration of social responsibility
Disclosure profitability and timely financial disclosures
and corporate growth. As a responsible
Corporate Citizen we tirelessly work to
gradually fulfill our mission. By seizing the
opportunities presented by the new era of Product Safety and Quality
transformation we continuously focus on Provide high-qual i ty products and services. Diverse Offerings Privacy
the environment and social responsibility. Customers Implement robust information security measures to and Information Security
We actively respond to the concerns and ensure the protection of customer privacyResponsible Marketing
expectations of both internal and external
stakeholders.Basic Rights Protection Sign labor contracts and remits social insurance
Training and Promotion in compliance with local law. Maintain competitive
Operational Sustainability Employees Compensation and Benefits salary levels provide multidimensional trainings for
Health and Safety employees. Maintain rigorous occupational health and
ESG Strategic Planning We c o n t i n u o u s l y o p t i m i z e t h e Work-Life Balance safety standard
governance framework identify and
assess key risks and develop measures
to establish a standardized transparent Estab l i sh mid- to long-term env i ronmenta l
Environmental Protection
and fair governance mechanism that management goals implement energy-saving and
Environmental Reduce Pollution Emissions
ensures sustainable development emission-reduction initiatives and promotes green
Enhance Energy Efficiency
office practices
Establish standardized procurement systems and
We prioritize employee rights by fostering We firmly believe that research and Win-Win Cooperation enhances supply chain management maintain a fair
a diverse inclusive and equitable work innovat ion are cruc ia l dr ivers o f Sustainable Supply Chain and orderly competitive environment. Build academic
environment. We will remain actively sustainable development. We are Partners Contribute to Industry exchange platforms and conducts industry training
involved in social welfare activities committed to ongoing investment in Development initiates industry-university-research cooperation
leveraging our expertise to contribute R&D to develop cutting-edge ophthalmic projects
greater value to society. technologies and products.Government Operate in accordance with Social Sustainability Product Sustainability the law Fulfills tax obligations enhance anti-bribery and anti-and Regulatory
corruption measures
Authorities Comply with business ethics
ESG Management System Materiality Assessment
To enhance ESG management practices Eyebright Medical has established a multi-tiered management system. The ESG report aims to comprehensively disclose key issues in the areas of environment social responsibility
The management team oversees strategic decisions integrating ESG principles throughout all business and corporate governance thereby enabling stakeholders to accurately assess the Company's ESG performance.processes. An ESG task force develops action plans to advance key environmental social and corporate In 2024 Eyebright Medical conducted a comprehensive materiality assessment to identify priority ESG topics
governance initiatives. This structured approach ensures the seamless integration of ESG goals into our business integrating past practices industry development trends and international ESG standards.practices fostering effective implementation across the organization.
16 172024 Environmental Social and Governance Report
Environmental
Eyebright Medical integrates the concept of green development into its corporate strategy and daily operations.By enhancing environmental awareness efficiently utilizing resources reducing waste and implementing green
operational practices the Company actively assumes environmental responsibilities and promotes harmonious
coexistence between humanity and nature.
18 192024 Environmental Social and Governance Report
Environmental Risk
Management
The Company strengthens its environmental
risk management capabilities in accordance with
regulations in China. It has established internal
procedures for emergency management and hazard
identification implementing effective measures such
as regular inspections environmental monitoring
and emergency response to strengthen risk control
Environmental Management and reduce the environmental impact of incidents.During the Reporting Period
A comprehensive annual environmental management
object ive system is supported by a robust
No incidents of environmental governance structure where the board provides
violations strategic oversight and the EHS department
coordinates efforts cross-functional efforts. Regular
No media exposure incidents related drills for environmental emergencies have been
to environmental issues conducted enhancing the emergency response
Eyebright Medical strictly fulfi l ls its environmental capabilities of responsible personnel from process
protection. The Company comprehensively strengthens its management to incident handling.environmental risk management mechanisms adopts eco-
friendly measures explores new energy infrastructure and
promotes green sustainable development. Its efforts aim to Conduct regular inspections of environmental facilities to check
achieve a win-win situation in environmental protection. operational and equipment wear status
Environmental Facility Timely maintenance is carried out to ensure the safe and effective
Inspections operation of all environmental facilities
Environmental Management System Regularly perform environmental monitoring to effectively track
pollutant emissions
Eyebright Medical prioritizes environmental protection as a core Environmental Actively engage in environmental impact assessments supervisory
mission adhering to the Environmental Protection Law of the Monitoring audits and clean production audits
People's Republic of China. The Company optimizes processes and
upgrades facilities to implement stringent standards significantly
improving environmental governance. In March 2025 Eyebright
Medical achieved ISO 14001 certification.Establish a comprehensive emergency management system for
To further its commitment to green development the Company environmental incidents
established an Environmental Health and Safety (EHS) department.This initiative aligns with national goals for carbon peak and Develop and refine the "Emergency Response Plan for Environmental
neutrality by 2030. Incidents" and other related documentsEmergency
Management Clearly outlining emergency response processes and handling standards
20 212024 Environmental Social and Governance Report
Pollution Prevention
Eyebright Medical is rigorously adhere to the Environmental Protection Law of the People's Republic Case Eyebright Yantai Wastewater Treatment Process Renovation
of China. Our pollution prevention strategies are embedded in all stages of research production
and operations.By emphasizing proactive measures over remediation we effectively reduce
pollutant emissions through installing environmental protection equipment process enhancements
and robust management practices thereby minimizing our impact on the environment.Through the renovation of wastewater treatment processes the wastewater treatment
plant achieved a"one increase one decrease" enhancing wastewater treatment
capacity while reducing costs.The Company complies with local environmental
assessment requirements by engaging qualified
third-party organizations to monitor pollution sources Wastewater Flocculation
including wastewater exhaust emissions and noise PH RegulationCollection Tank Reaction
in accordance with local environmental assessment
requirements. During the Reporting Period four
monitoring tests were conducted and all results were
within regulatory discharge limits. MBR A2O Process
Clean-Water
Reservoir
During the Reporting Period
No media exposure incidents related
to environmental issues for the
Company or its subsidiaries
Air Quality Management
Waste Water Management Eyebright Medical prioritizes environmental responsibility by strictly adhering to the Air Pollution Prevention and
other relevant regulations. The Company adopts a scientific and rigorous approach to air pollution prevention
and emissions control.The Company complies with national and local standards by implementing effective emergency management
The Company implements a variety of effective purification techniques including activated carbon adsorption
measures for water pollution. Industrial and domestic wastewater generated during daily operations is
vacuum cleaning and high-efficiency grease purifiers. During the reporting period the Company engaged
processed through the Company’s treatment systems and safely discharged into municipal sewer networks upon
professional agencies to conduct regular monitoring of emissions and results from non-organized tests were
meeting relevant discharge standards.confirmed compliance with standards.
22 232024 Environmental Social and Governance Report
Case Empty Tube Recycling Program
Case Fume Hood System
Starting in 2024 the Company Skin brand "HiGenie" under the Company launched a " Empty
Tube Recycling" program. This initiative encourages consumers to participate in sustainable
consumption through the distribution of no-threshold coupons and the exchange of empty
The Company has equipped high-efficiency fume hood systems to enhance laboratory tubes for genuine products. Collected tubes will be sent to a third-party recycling facility
safety and maintained environmental quality. These systems promptly and effectively for cleaning and shredding where they are processed into recycled pellets for use in
expel harmful substances generated during experiments effectively controlling the manufacturing processes.spread of these substances at the source. This initiative safeguards the health and
safety of laboratory personnel and ensures the stable operation of equipment and
instruments.Waste Management
The Company strictly complies with the Solid Waste Pollution Prevention and Control Law and the Medical Waste
Management Regulations of the People's Republic of China. The Company has established relevant management
systems encompassing the entire process of solid waste generation collection storage transportation
utilization and disposal ensuring effective environmental pollution prevention and control.The Company's solid waste includes general and hazardous waste. General solid waste consists of materials
preparation waste packaging waste and household garbage which are entrusted to qualified third-party
organizations for transportation recycling and disposal. Hazardous waste primarily includes experimental waste
liquids used reagent bottles and spent activated carbon. The Company implements strict controls on hazardous
waste storing it separately in designated collection devices based on its category and nature. Qualified third-
party organizations are engaged for the harmless
treatment of hazardous waste to ensure proper
disposal. During the Reporting Period
The Company conducts regular training sessions for
hazardous waste management that cover applicable The Company headquarters generated
laws regulations and management systems 9.646 tons of recyclable waste
ensuring effective management at every stage.
24 252024 Environmental Social and Governance Report
Noise Management Resource Management
The Company strictly adheres to national and local standards such as the Industrial Enterprise Boundary
Environmental Noise Emission Standards ensuring that boundary noise complies with environmental emission
standards. This helps reduce and prevent noise pollution and its harmful effects on the environment and Eyebright Medical continuously strengthens its regular resource usage management focusing
human health. Additionally the Company thoughtfully designs the layout of its facilities and scientifically plans on reducing reusing and recycling resource consumption at the detail level. The Company
production processes to control noise generation and propagation at the source. comprehensively improves resource utilization efficiency fully leverages its innovative advantages
and promotes the implementation of resource recycling and green alternatives.Noise Reduction Measures Case Acoustic Enclosure Water Resources Management Water-Saving Measures
Fans Air Compressors and Similar Equipment Optimizing the opening and closing times of
main valves to control water flow effectively
Eyebright Medical places a high emphasis on the
The installation of an acoustic containment
Implement fundamental vibration damping impact of water resource consumption on the Limiting water flow to reduce consumption
system has successful ly reduced
measures to minimize noise during equipment environment and is committed to the protection
operational noise within the production
operation conservation and rational use of water resources. Displaying water-saving signage
process significantly improving overall
The Company regularly monitors water usage encouraging the practice of turning off Utilize specialized mufflers to further reduce environmental conditions.faucets when not in use
the noise intensity of equipment emissions promptly analyzes any anomalies and immediately
ensuring quieter operation formulates and implements targeted water-saving
measures. In 2024 the Company was selected into Conducting routine maintenance of water
the Beijing Water-Saving Enterprise Directory. supply and storage facilities
Various Fluid Transfer Equipment
Comprehensive Upgrade
Implement fundamental vibration damping Case of Purified Water Equipment Case Rainwater Retention Pits
measures to reduce vibrations during
operation
Install soundproof walls and doors to block
noise transmission paths effectively isolating Implement advanced membrane separation
sound from the surrounding environment technology and intelligent control systems Use peak shaving and flood control
to precisely adjust operational parameters methods to alleviate drainage pressure
effectively minimizing water resource waste ensuring the stable operation of the
drainage system
Production Equipment Prevent flooding within the park to ensure
the safety of production equipment and
road accessibility
Install soundproof enclosures to contain the
noise generated by equipment preventing its Settle oil heavy metals and other
spread pollutants from rainwater to protect the
aquatic ecosystem
Utilized advanced soundproofing materials
and scientifically designed noise reduction Utilize rainwater resources for landscaping
processes on crystal freezing fixtures irrigation reducing the Company's water
achieving an overall noise reduction of costs
approximately 10 decibels which effectively
improves the working environment for
operators
26 272024 Environmental Social and Governance Report
Energy Management Green Production
The Company act ive ly promotes During production processes Eyebright Medical adopts advanced environmentally friendly technologies and
the systematic construction of its equipment to effectively reduce energy consumption and waste emissions. The Company continuously optimizes
energy management system and has production workflows to enhance resource efficiency minimize waste generation ensuring full compliance with
established regulations such as the environmental standards."Electricity and Energy Conservation
Management Guidel ines" to drive
diverse energy-saving initiatives and Automated Packaging Production Line
continually explores opportunities Case Smart Factory
for energy reduction. The Company
effectively reduces energy usage
enhances energy ef f ic iency and
fosters a sustainable product ion
and operational model focused on Tianyan Medicine — a subsidiary of
energy conservation and efficiency Eyebright Medical leverages new The production line was upgraded from
enhancement. In February 2025 the manual to semi-automated packaging and industrialization as a driving force to
Company achieved ISO 50001 energy vision inspection system was introduced continuously enhance the intelligence
management system certification. to improve error detection accuracy and of smart factories smart workshops
efficiency. and automated production lines. This
commitment has earned it the "Smart
Energy-Saving Measures Automated Data Recording Manufactur ing Workshop"honor
f r om J i angsu P rov ince f o r i t s
"Intel l igent Transformation and
The purification HVAC system in the production area utilizes variable frequency technology to optimize Digital Networking" as well as the
energy efficiency through i ntelligent cycling control of indoor/outdoor units. "Excellence in Quality Management
Outdoor lighting systems use programmable timer switches to deactivate at predetermined intervals Award" from Ganyu District.while indoor switches integrate visual/auditory shutdown alerts. Centralized monitoring teams conduct
Data is automatically recorded in testing
inspections before leaving to ensure all lights are turned off reducing unnecessary energy consumption. for quick query and analysis. saving paper
The lighting system in the underground parking area has been upgraded to save energy by turning off resources and improves testing efficiency by
50%.
non-essential lighting fixtures ensuring necessary illumination while maximizing energy savings. This
initiative is expected to save nearly 10000 kWh annually. Scanning and Inventory System
Certain production areas have installed photovoltaic systems to harness solar energy a clean energy
source reducing reliance on non-renewable energy.The Company explores technological upgrades for energy conservation and emission reduction
including waste heat recovery for air compressors. This captures and reuses heat from cooling water
enhancing waste heat utilization and improving overall energy efficiency.Products quick ly generate a UDI that
includes key attributes and traceability data
streamlining inventory operations for better
management.Kanban Management
A Kanban management system allows to
monitor real-time progress and adjust task
priorities .
28 292024 Environmental Social and Governance Report
Green Office Practices Climate Action
Addressing climate change has become a global trend. Eyebright Medical is committed to
The Company actively promotes green office practices sustainable development principles. The Company continuously monitors climate change trends
and eco-friendly commuting by implementing digital and prioritizes climate action within its growth strategy. Actively identifying and systematically
and paperless operations effectively reducing evaluating climate-related risks and opportunities we formulated tailored strategies to mitigate
resource waste and energy consumption. It enhances risks to business continuity and stability.energy-saving and environmental awareness in office
areas fostering a participatory and collaborative Climate Risks
atmosphere. Through these practices the Company
demonstrates its commitment to low-carbon
and environmentally friendly principles in daily Risk Type Potential Impact of Risk
operations.Extreme weather events (floods and typhoons) threaten supply
Acute chain stability making it difficult to ensure consistent product
supply
Physical Risks
Long-term climate shifts can impair employee health and
Chronic
productivity affecting R&D and manufacturing efficiency
Policy and Implementation of carbon emission control policies may increase
Regulation requirements for climate response and disclosure
Shift in market preferences towards low-carbon products may
Market
Transition Risks result in a decline in sales of medical equipment
Lagging energy technologies could lead to increased production
Implementing a paperless approach by using electronic media for drafting editing Technology costs
circulating and approving documents Decreased stakeholder interest in non-environmentally friendly
Office Supplies Reputation
Establishing a system for planning and controlling printed materials requiring advance products potentially harming brand reputation
Management
applications and approvals to prevent waste
Initiatives
Practicing responsible procurement of office supplies promoting reuse and conserving Opportunities and initiative brought by climate change
office materials
Leverage government incentives for low-carbon initiative
Develop energy-saving and
emission reduction plans Engage in partnerships between academia and industry
Promoting the use of energy-saving light fixtures and encouraging employees to switch Use clean energy sources Empower supply chains for sustainability
Electricity off indoor lighting when not needed especially after hours or during extended absences
Conservation Ensuring that computers printers and other office devices enter energy-saving mode
Management during intermittent use and turning them off and unplugging when not in use Resource Products and
Initiatives Energy Sources Market Resilience
Adjusting air conditioning temperatures to avoid excessively high or low settings thereby Efficiency Services
reducing overall energy consumption
Utilize renewable materials Create low-carbon products Implement low-carbon green
Implement resource-efficient design manufacturing processes
Adopt more efficient transportation modes Establish diversified production Converting Company shuttles and official vehicles to new energy models. arrangements across multiple
New Energy Vehicle Optimize production and distribution
processes locations
Initiatives Encouraging employees to use public transport by providing support through transit
cards collectively fostering low-carbon commuting practices
The Company actively embraces the concept of low-carbon living advocating for green production and office
practices. It conducts extensive training on energy conservation and low-carbon initiatives continuously
enhancing employees' awareness of the importance of climate change. We encourage everyone to take practical
actions collectively contributing to environmental protection.
30 312024 Environmental Social and Governance Report
Social
Eyebright Medical actively fulfills its corporate social
respons ib i l i ty emphas iz ing sc ient i f i c research
innovation and academic exchanges while ensuring
the highest product quality. The Company prioritizes
employee growth through providing robust career
development platforms engages in social welfare
activities and leverages its resources to contribute
to public health improvement.
32 332024 Environmental Social and Governance Report
Innovation Empowerment R&D Investment Million (RMB)
YOY
YOY 20.80%
Techno log i ca l i nnova t i on i s c r i t i c a l 61.23%
to ma in ta in ing the Company ' s co re 159.82132.30
competitiveness. Eyebright Medical focuses
82.06
Eyebright Medical views innovation as the cornerstone of high-quality development. In the ophthalmic field on cutting-edge technology consistently
we strategically advance research initiatives strengthen our R&D team and foster a comprehensive industry- investing a significant portion of resources
academia-research platform. We continuously build our cutting-edge technological capabilities and research into R&D to enhance innovat ion and
excellence while establishing a robust support system to safeguard our scientific innovations. efficiency supporting the achievement of the
Company's strategic goals. 2022 2023 2024
R&D Investment Over the Past Three Years
as of Dec 31 2024
Scientific Research Framework
Recently Introduced Products
Eyebright Medical refines its R&D management To enhance project R&D efficiency and quality the
system through optimizing R&D regulations and Company focuses on building a high-quality R&D
strengthening innovation capabilities. A project team. We implement a regular training program
leader system ensures end-to-end oversight of that covers covering advanced technical knowledge
product development—from market research to post- standardized procedures and regulatory compliance
market feedback enhancing researcher expertise which boosts the technical innovation and operational
received NMPA approval in Jan2025
coordination efficiency and product development standards of our R&D personnel ensuring effective
success rates. project execution and quality control.THIN CUSTOMIZED
Ultra-thin double-concave design 10 models for precise matching
Company R&D Workflow Ideal performance in the eye gap Personalized options available
Market Research Preliminary R&D Project Experiments Initiation "Intelligence -Driven Innovation: Advancing Together in R&D"
2024 Annual Eyebright Medical R&D Work Conference
Product Type Testing-
Registration Clinical Trials Clinical Trials
WIDE STABLE
Product Market Launch- Market Clinical 6.0mm optical region with zero Stable arch height with
Registration Post Research "Innovation Sets Sail: Collaborating for Success" spherical aberration excellent support
Patent Training Session
High-quality visual performance Long-term intraocular stability
34 352024 Environmental Social and Governance Report
China mainland Intellectual Property Protection
Eyebright Medical rigorously implements China's innovation-driven development and intellectual property power
strategies by adhering to the Patent Law of the People's Republic of China and Copyright Law of the PRC. The
Company has established a robust copyright management system through institutionalizing policy documents
such as the Intellectual Property Management Manual Patent Administration Protocols Trademark Registration
Governance Procedures and Copyright Compliance Guidelines. It conducts systematic patent evaluation
disclosure and commercialization initiatives to enhance technology transfer efficiency thereby elevating its
management capabilities to global standards in alignment with national innovation priorities.Multi-Model Preloaded Aspheric
Intraocular Lens System / Preloaded iBright High-order Aspheric Soft 7 types of Soft Hydrophilic Contact Lens
Hydrophilic Contact Lenses
Intraocular Lens System
4139
Patents Applied Patents Granted
417256
Total Patents Applied Total Patents Authorized and Valid
International patents covering Europe USA Japan South Korea and Singapore
iBright Bionic Compound-Eye AINNOVI3D Visualization Handheld Thermal Pulsation Device
Defocus Spectacle Lens System for Meibomian Gland Dysfunction
Experimental Ethics
The Company strictly follows welfare and ethical review requirements for animal experiments. Pre-experiment
assessments evaluate necessity scientific value and potential harm.We prohibit any meaningless abuse or
unnecessary killing of animals halting experiments that lack scientific significance or are non-essential."3Rs" principle of Reduce Replace
and Refine guilds the implementation
of animal experiments. We carefully
Rinsing Solution for Rigid Gas Hydrogen Peroxide Multi-
Ophthalmic Viscoelastic Agent plan and design experiments to
Permeable Contact Lens Purpose Solution
minimize the use of animals actively
seek alternative methods to reduce
dependency and cont inuously
opt imize procedures for more
Thailand Registration certificates for multiple preloaded intraocular lenses humane practices minimizing animal
suffering.Malaysia Renewal of registration certificates for various preloaded intraocular lenses
Bangladesh Registration certificates for multiple preloaded intraocular lenses We ensure that experimental animals
enjoy basic rights and respect their
Pakistan Registration certificates for multiple preloaded intraocular lenses ability to express emotions. Our
commitment to treating animals
Indonesia Registration certificates for various soft hydrophilic contact lenses with kindness and respecting their
Brazil GMP Certification lives is integral to our entire animal
experimentation process.Hong Kong Inclusion in the Hospital Authority’s List of Licensed Suppliers
3637
International2024 Environmental Social and Governance Report
Collaborative Industry Advancement
Eyebright Medical fosters domestic and international academic exchanges creating a global platform that
integrates medical research with clinical practice. We participate in the Formulation of Sector Standards
collaborate with universities to train ophthalmic talent and strengthen the link between research and education
contributing to innovation in ophthalmic healthcare.iBright Defocus Lens Data
Release Event
Academic Exchange
Experts engaged in multidimensional discussions
on myopia prevention frame glasses and
During the Reporting Period Conference Highlights the real-world data of iBright lenses praising
Eyebright Medical’s comprehensive approach to
precise myopia management.
2
International Exhibitions
Elite Optical Fitting Studio
20 Combining in-person and online formats
National Conferences clinical experts provided fitting demonstrations
discussing product features fitting techniques
70 and patient assessments while addressing
Regional Meetings questions to keep optometrists informed about
new technologies and products.Eyebright Medical considers communication and 61
collaboration essential for innovation. We actively Self-hosted Meetings
engage in domestic and international academic
exchanges organizing forums and seminars to
connect with ophthalmic experts and address key 2783
challenges in the field. Online Participants
In 2024 Eyebright Medical participated in major
national conferences including the National 29088 High-Order Aspheric Clinical Sharing
Ophthalmology and Cataract Conferences and Total Professional Viewers and Soft Lens Release
international events such as APAO and ESCRS. We Accurate Refraction and
also actively joined multiple provincial and municipal Focus ing on Or thokera to logy l ens and Vision Improvement
academic conferences across China. Our innovative 141477minutes encompassing defocus RGP rigid lens care
Viewing Time A seminar brought together experts from
technologies garnered global recognition at various systems defocus glasses and defocus soft lenses industry clinical and research sectors to focus
regional meetings. we invited regional KOLs and young optometrists
to share clinical experiences enhancing the on clinical topics and global advancements in
market influence of iBright and promoting our ophthalmology. This enhanced the visibility of the
entire optical product line while providing a iBright brand established its premium image
learning platform for practitioners to elevate and cultivated a high-end user base expanding
industry standards. market share.
38 392024 Environmental Social and Governance Report
School-Enterprise Cooperation
SHOW Your Sherlock Eye
Now in its fourth year the event evolved into "SHOW iBright Spark Program
Your Sherlock Eye - A Journey into Orthokeratology"
gaining significant attention from industry experts Eyebright Medical's "iBright Spark Program" strengthens R&D and talent development through university-
and optometrists becoming a highly impactful industry partnerships. By adopting innovative models like resource sharing joint training and curriculum co-
academic activity. creation the program jointly builds practical training bases and integrated education-industry platforms with
universities. This initiative delivers market-aligned professionals with practical competencies to the ophthalmic
optics sector providing robust talent support for the industry's sustainable prosperity and development.Effective Prevention and Comfortable Multifocal Intraocular Lens Training Camp
Balance
Continuously streamed online this camp helps physicians
In a sess ion combin ing theory comprehensively learn about multifocal lens covering
and clinical practice many online everything from optical theory to surgical planning and clinical
physic ians learned personal ized practice. The content is structured in a progressive manner—
strategies for myopia prevention and starting from foundational concepts advancing through
the precise fitting techniques of iBright procedural planning and culminating in real-world clinical
lenses enhancing their clinical skills. applications—to support physicians’ professional advancement.Standard Establishment
We believe high-quality corporate standards are the foundation for safeguarding innovation technical strength
production capacity and social responsibility. They also serve as a bridge for communication and trust between
During the Reporting Period Since 2022
the Company and customers partners industry organizations and the public and as a key tool to enhance
corporate competitiveness. Eyebright Medical has been actively engaging in and advancing the standardization
Collaborated with a total of 15 universities
of ophthalmic medical devices to promote quality development of the eye health industry.Established partnerships with
universities 5 Extended reach to 12 provinces and municipalities
During the Reporting Period the Company participated in revising 7 standards and contributed to 2 industry Donated over RMB 4.5 million in materials
reports Donated: over RMB 1.2 million
in materials Provided 500 hours of training
Empowered over 2500 students
Standard/Report Name Participation Benefited: more than 1400
students Benefited more than 10000 vision care professionals
GB 11417.2-20XX Ophthalmic Optics - Contact Lens Part 2: Rigid Contact Lens In revision and validation
GB 11417.2-20XX Ophthalmic Optics - Contact Lens Part 3: Soft Contact Lens In revision and validation
YY T0942-20XX Ophthalmic Optical Intraocular Lens Implant Systems In revision and validation
Post-Market Surveillance for Medical Device Manufacturers In revision and validation
Orthokeratology Lens Fitting Guidelines Participation in Drafting
Soft Contact Lens Fitting Service Standards Participation in Drafting
Application Guidelines for Myopia Control Related Frame Glasses Participation in Drafting
Southern Institute of the National Medical Products Administration: "Report on
Participation in Drafting
High-Quality Development of the Chinese Ophthalmic Medical Device Industry"
National Vocational Education: Textbook on Optical Technology for Contact Lens Participation in Drafting
Fitting (Third Edition)
40 412024 Environmental Social and Governance Report
Training and Talent Cultivation
Three Major Training Bases
Eyebright Medical collaborates with renowned ophthalmic hospitals Opened in 2021 the t ra in ing
and industry associations to establish three training bases in China program have trained over 550
Eye Valley Tianjin Eye Hospital Optometry Center and its Beijing professionals from more than 370
headquarter. These centers offer multi-dimensional and tiered learning hospitals and vision centers across
platforms designed for optometry professionals at different stages. 30 provinces. This systematic
The training program covered cutting-edge theoretical knowledge approach has enhanced participants'
in standardized fitting protocols and myopia prevention and control skills and competencies supporting
significantly enhancing the expertise and practical skills of grassroots talent development in the eye care
optometry practitioners in the field of refractive error management. industry.IBRIGHT ELITE Youth Paper Award
Founded in 2021 the IBRIGHT ELITE Youth Paper Award in collaboration with the International
Conference on Visual Health Innovation encourages young ophthalmologists vision care
practitioners and students to explore the fields of ophthalmology and visual health. It promotes
academic exchange and innovation fostering the growth of future leaders in the eye care
industry.v During the Reporting Period
Premier Paper Award (Best Winner) 3 recipients
Excellence Paper Award 6 recipients
Outstanding Paper Award12 recipients
During the Reporting Period
Conducted 5 training A calculated total 118 Engaged over 200 Popular Paper Award25 recipients
sessions hours training time participants
Excellent Poster Award25 recipients
Supported: 71 Young
Scholars
C hina Eye Valley
Total Young Scholars
Funded: 234
Tianjin Eye Hospital Optometric Center
Total Funding Amount:
Over RMB 350000
Eyebright Medical Beijing headquarter
42 432024 Environmental Social and Governance Report
Accessibility of Medical Services Product Responsibility
Eyebright Medical regards product quality as the lifeline to its operations. We uphold strict safety standards
build a sustainable supply chain and optimize customer service to ensure every step—from raw material
procurement to delivery—meets the highest industry standards.Quality Management
Eyebright Medical strengthens its quality and safety Using the ISO 9001 framework we comply with
management systems through robust organizational regulations such as GB/T42061 and ISO 13485
structures policy development regulations and integrating quality risk management into our
training thereby ensuring effective operation that processesand comprehensively ensuring the robust
Eyebright Medical is committed to creating value by providing high-quality convenient eye health services. We safeguards patient health. operation of the Company's quality management
leverage technology including artificial intelligence to improve the quality and accessibility of ophthalmic care system.ensuring that grassroots communities enjoy fair fast and convenient eye health services. Quality Management System
During the Reporting Period
Case Pioneering 24-Hour Smart Contact Lens Store in China ISO 9001 GMP 1 7 successful external inspections all passed
on the first attempt
N O major product quality incidents have been
In 2024 we partnered with Meituan Health ISO 13485 EU MDR reported
to launch China's first 24-hour smart
contact lens store—Meiyue Tong TOPPOP
Smart Store—in Beijing. Citizens can place The Company has successfully undergone four KGMP CE Certificate
orders anytime via the Meituan platform. national product inspections in 2017 2020 2022
Once an order is received a humanoid AI and 2024 with all results confirming that our
robot automatically sorts and retrieves products meet technical requirements demonstrating
the product prints an electronic receipt GB/T42061 Medical Device License the effectiveness of our quality management system.seals the items and deposits them into
a self-service pickup cabinet. A delivery
rider then collects the package using a
pickup code. The 24 - hour smart store
not only provides citizens with faster 2020 2022
more precise 'zero - distance' purchasing
20172024
experiences for contact lenses but also
significantly enhances store productivity
and operational efficiency. % Pass Rate in Natio0 nal S0 upe1 rvision
44 452024 Environmental Social and Governance Report
Quality and Safety Training
CNAS testing center
We prioritize the enhancement of quality awareness
across all employees and quality competency among
professionals. The Company organizes diverse
training sessions tailored to job roles covering
topics such as quality knowledge specialized skills
procedures relevant laws industry standards
and professional ethics. Through comprehensive
training all personnel shall thoroughly comprehend
the criticality of quality and safety acquire essential
knowledge and skills and effectively implement all During the Reporting Period
quality safety regulations thereby establishing a the Company conducted nearly 5 0 quality and
robust foundation for the Company's sustainable safety training sessions.development and quality enhancement.Customer Service
Service capability and quality are key strengths for Eyebright Medical reflecting our brand image. We prioritize
customer needs through responsible marketing and a comprehensive service system. We continuously refine
service process management and proactively gather customer feedback to deliver superior user experiences.Communication Platforms Matrix
Case Customer Satisfaction Survey
Our testing center has received
laboratory accreditation from the
China National Accreditation Service Market Research Online Services 400 Customer Average Satisfaction Score Exceeds 9.8/10
for Conformity Assessment (CNAS) Service Hotlines
making i t the f i rst enterpr ise- In 2024 the Company surveyed our
based lab in China for intraocular agents and partnered hospitals service and
lens testing. The center is equipped product satisfaction covering usability
with advanced testing equipment Intelligent Self- Customer Forums Customer effectiveness and delivery processes.continuously ensuring the quality and Service System Satisfaction Surveys Resu l t s showed tha t t he ave rage
safety of our products. satisfaction score exceeded 9.8 indicating
high satisfaction with our products.Quality Safety Management and Control We have establ ished a standardized survey
mechanism and conduct customer satisfaction
surveys every six months.Through thorough data
The Company has established a "Risk Management Control During the Reporting Period
Procedure" to identify analyze evaluate and control Non-Conforming Product Control Procedure
collection and analysispotential issues in products
and services are proactively identified.Targeted
risks related to product safety. These risks are regularly NOAdverse Event Control Team improvement measures are implemented to Major Customer Complaints Occurred
reassessed and improved standardizing and monitoring continuously enhance product quality and optimize
all aspects of product development production facility Informed Service System service experience ensuring timely identification and
management and material management to ensure stable resolution of potential problems to deliver superior
and reliable product quality. Product Recall Control Procedure services to clients.
46 472024 Environmental Social and Governance Report
Sustainable Supply Chain Employee Development
Supplier Management
As a responsible STAR Market-listed company Eyebright Medical sees supplier management as an extension
of our corporate values. We follow three key principles: selecting high-quality suppliers aligned with our
culture building long-term partnerships for sustainability and integrating corporate social responsibility and Eyebright Medical values employees fostering a culture centered on innovation openness integrity and
environmental protection into our supply chain. This approach ensures exceptional product quality and promotes shared success. We respect each individual and aim to create a diverse and inclusive workplace. By providing a
a healthier more sustainable medical ecosystem. platform for talent expression we inspire creativity and work together to achieve personal and company goals.Employees Rights and Interests
Tiered Suppliers are classified evaluated and performance-tracked according to relevant
Management rules
Compliance in Hiring
Eyebright Medical upholds equality and inclusiveness in hiring strictly following the Labor Law of the PRC.Qualified suppliers are assessed and recorded with a dynamically updated We have implemented systems like the "Personnel Recruitment Management System" and the "Retired
Evaluation System list to ensure safe stable and efficient procurement
Reemployment Management System" to ensure a fair hiring process and protect the rights of employees and
applicants.Established an "On-site Inspection System for Key Suppliers" to As of the End of the Reporting Period
evaluate the production environment quality management systems
On-site Inspections product manufacturing processes and delivery capabilities of critical The Company employs a total of 2 2 9 4 employees
suppliers
Responsible Procurement Gender Distribution Age Distribution Ethnicity Distribution
Establishing procedures Planning requirements Signing agreements
During the Reporting Period
NO Female Employees <30 41-50 Ethnic MinoritiesReturns Due to Incoming Inspection Issues have been Reported
Male Employees 31-40 >50 Han Chinese
48 492024 Environmental Social and Governance Report
Equal Workplace Cultivation and Development
The Company promotes fairness and justice in
recruitment training and promotion treating all Compensation Incentives Promotion Mechanism
employees equally regardless of region ethnicity age
gender religion or culture. We prioritize the rights Eyebright Medical regards employees' work Eyebr ight Medica l v iews employees as key
of female employees by adhering to relevant laws enthusiasm and innovative capabilities as the driving contributors to the Company's success. We employ
and providing equal opportunities and professional force for the Company's sustainable high-quality both internal selection and external recruitment
growth. development. We have developed a comprehensive to meet business needs while providing career
compensation system that aligns with market- development opportunities for our staff optimizing
Eyebright Medical places high priority on protecting based standards offering incentives like salaries human resource allocation.the rights and interests of female employees strictly performance bonuses and equity options to boost
complying with the Constitution of the PRC the Law motivation and loyalty. We champions a high-performance-oriented
on the Protection of Women's Rights and Interests
corporate culture that prioritizes efficiency while
and the Special Regulations on the Labor Protection
In 2024 we strictly adhered to relevant laws and ensuring fairness. Our performance management
of Female Employees. We provide female employees
board resolutions to implement stock incentives system is aligned with business goals and cascades
with fair and equitable career opportunities and
for qualified employees under the "2021 Restricted down to departments and individual employees
ample professional development space. The Company
Stock Incentive Plan" allowing employees to share linking company performance closely with personal
fosters a supportive professional environment for
in the Company's success and stimulating core achievements.women through its corporate culture and management
talent's motivation and innovation and encouraging
framework.their long-term commitment to the Company’s
development.We also respond to government initiatives by
Key Performance
providing job opportunities and benefits for people Work Plans Work AttitudeIndicators
with disabilities fulfilling our social responsibility. In During the Reporting Period
2024 we offered positions to 12 disabled individuals
Granted 2 0 6 9 8 2 incentive shares to 78 In 2024 the Company conducted a talent review to at our headquarters.employees create personalized career development plans for
core employees establishing clear promotion paths.During the Reporting Period
5 0 % of the senior executive team
consists of female members
Female
Male
50 512024 Environmental Social and Governance Report
Talent Development Internal Knowledge Sharing
Eyebright Medical considers The Company emphasizes the importance of knowledge management and experience sharing by inviting experts
employees our most valuable and key professionals to conduct thematic sharing sessions across diverse domains. These initiatives not only
a s s e t p r i o r i t i z i n g t h e i r facilitate the effective circulation and accumulation of institutional knowledge but also stimulate employees'
s k i l l e n h a n c e m e n t a n d innovative thinking and learning capabilities through systematic intellectual asset transfer.career development as key
components of our HR strategy.We optimize training processes
to align with strategic goals
and business needs creating
a comprehensive system that
includes leadership business
empowerment onboarding and
internal knowledge sharing.This investment strengthens our
workforce and helps maintain
our compet i t ive edge in a
dynamic market.Leadership Training
During the Reporting Period
Held 6 Internal Knowledge Sharing Sessions Reaching Nearly 500 Participants
Effective Role Transition and Ultra-Precision
01 Communication in 03 Professional Competencies 05 Processing
the Workplace for R&D Engineers Techniques
Peking University Economic Management Training Program
In 2024 Eyebright Medical launched the "Peking University Economic Management Training
Program" bringing middle and senior-level executives and partners to learn about international
trends cutting-edge research and advanced management practices. This initiative broadens their Project Management Business
perspectives helping them understand industry challenges and opportunities to develop forward- 02 and Practices in 04 Fundamentals of 06 Negotiation Innovative Medical Ophthalmology
looking strategies and high-performance teams enhancing market competitiveness and digital Skills
Device Development
growth.
52 532024 Environmental Social and Governance Report
Business Empowerment Training Welfare and Care
Eyebright Medical has established a tiered business enablement framework and conducted Lean Production
Quality Management Training to enhance decision-making. Employee Benefits
The Company prioritizes employee health management by adhering to legal requirements and offering
Lean Production Quality Enhanced Internal Audit additional benefits such as supplementary medical insurance health check-ups annual leave holiday gifts and
Management Training Professional Training Beijing Household Registration Quotas. These diverse welfare measures enhance employee development well-
being and overall sense of belonging.Statutory Benefits Company Benefits
Pension insurance Work Injury Supplementary Medical Insurance
English Language Training Compliance Management I n s u r a n c e U n e m p l o y m e n t Training
Insurance Maternity Insurance Annual Health Check-Ups
Medical Insurance
Specific Disease Screening for Female Employees
Housing Provident Fund Employee Assistance Program (EAP)
New Employee Training General Skills Training
Statutory Holidays and Paid Leave Holiday Gifts and Special Bonuses
The Company places great importance on onboarding We emphasize the enhancement of general skills Free Shuttle Bus Nursing Rooms and Gym Facilities
new employees establishing systematic training across all employees. Based on talent assessments
frameworks to accelerate their integration into the we carefully select external online training resources
workplace. In 2024 we updated the "Onboarding and provide learning opportunities through online
Plan" and "Knowledge Program" to help new hires platforms for both headquarters and subsidiaries.better understand company culture and regulations We also establish "learning groups" to encourage Democratic Communication
deepening their recognition of our values and employees to share personal insights helping them
enhancing team belonging. improve skills and broaden their perspectives. The Company listens to employee voices prioritizes fostering an open communication culture. We utilize various
channels to understand employee needs for timely responses. Continuous process optimization and work
environment improvements enhance employee satisfaction and foster a positive corporate culture.During the Reporting Period Training Overview
179
Total Sessions Employee Representative Assembly
4595 Multi-Channel Employee Relations Specialists
Total Participants Communication
Mechanisms
Corporate Newsletter:
28338 hours
Total Duration
54 552024 Environmental Social and Governance Report
Work-Life Balance
The Company prioritizes work-life balance by creating an employee-centered support system that addresses
diverse needs.To meet diverse needs
We have established nursing rooms for breastfeeding mothers built basketball courts and gyms for
fitness enthusiasts and provided shuttle services covering major residential areas and transport hubs
to ease commuting.The Company embraces a "people-oriented" management philosophy fostering a vibrant workplace through
diverse activities that promote work-life balance. We enhance cultural identity and team cohesion through
meaningful rituals nurturing a caring and growth-oriented environment where employees find happiness and
grow with the Company.Eyebright Medical World Eyebright Medical
Book Day Initiative Sports Day
Warmth and Care Co-Creation of Comprehensive
During Festivals Interests and Values Well-Being Support
2024 Team-Building Trip Fourth Employee
Photography Contest
56 572024 Environmental Social and Governance Report
Occupational Health and Safety Safety Production
The Company adheres to the principle of Safety
Occupational Health First Prevention as Priority and Holistic Governance
to strengthen safety responsibilities and enhance
overall performance effectively reducing workplace
Eyebright Medical prioritizes employee health by upholding the highest safety standards. We comply with accidents and occupational diseases. We have Safety First Prevention as Holistic
relevant laws including the Safety Production Law Occupational Disease Prevention Law and more. We achieved Level 3 Certification in safety production Priority Governance
continuously invest in safety management to provide a secure work environment. In March 2025 we achieved standardization.ISO 45001 Occupational Health and Safety Management System certification.Training on Safety Production
We prioritize safety education by regularly providing
training on safety production fire safety and
emergency escape to improve employee awareness
and skills.Emergency Management
During the Reporting Period
NO Serious Workplace Accidents occurred To standardize emergency responses the Companyhas developed an “Emergency Response Plan forProduction Safety Incidents” for production safety
incidents including comprehensive and specialized
plans. We maintain emergency supplies and conduct
regular drills in fire chemical and biological safety
to enhance our response capabilities and minimize
risks.
58 592024 Environmental Social and Governance Report
Serve the Society Medical Donation
Eyebright Medical actively supports the "Healthy
China" leveraging its strengths to provide grassroots
medical aid.In 2024 we donated surgical supplies including
Eyebright Medical views serving the community intraocular lenses viscoelastic and reading glasses
as a fundamental responsibility. Committed to to regions like Xichuan Xixia Neixiang in Henan
advancing global eye health the Company provides Gande in Qinghai and other areas. These efforts
cutting-edge ophthalmic technologies and actively delivered sight to underprivileged patients.supports social initiatives. This includes medical aid
to several countries assistance for cataract patients
help for vulnerable groups and myopia prevention
awareness among children. These efforts showcase
the Company's dedication to social responsibility.International Aid Initiatives
In 2024 in collaboration with Chinese medical teams
we helped ophthalmic patients in countries like
Venezuela Equatorial Guinea and Ethiopia restore
clear vision. This initiative significantly contributes to
global health efforts.
60 612024 Environmental Social and Governance Report
Public Welfare and Charity
During the Reporting Period
Eyebright Accompanies Your Growth series
Eyeb r i g h t Med i c a l i n New Year Warmth Campaign E y e b r i g h t M e d i c a l i n
collaboration with the China collaboration with the Beijing
Charity Federation Weihai Overseas Chinese Charity
City Civil Affairs Bureau Foundation and other related
and Weihai City Charity organizations launched the
Federation organized the "Overseas Chinese Care for
"Eyebright Accompanies Fangshan—New Year Warmth"
Your Growth" in Weihai campaign. We provided care
Shandong. We donated packages to over 200 families
backpacks s ta t ionery in the Da’anshan Township of
and sports equipment to Fangshan District spreading
underprivileged children warmth in the New Year.b r ing ing them ho l i day
gifts and warm wishes on
Children's Day.Service Activity for Overseas Chinese During the Double Ninth Festival
Eyebright Medical partnered with
the Beijing Overseas Chinese
Service Center to host the "Warm
Double Ninth Beautiful Life"
service event. We distributed
"Warm Doub le N in th" ca re
packages to elderly members of
the overseas Chinese community
conveying holiday greetings and
enhancing their sense of well-
being and happiness.Filial Piety and Respect for the Elderly Activity The Shangha i Char i ty Foundat ion
launched the charity project featuring
the inaugural "Health Science Outreach
to Communities: Zero Distance Service
Eyebright Medical launched the "Eyebright Eyebright Medical conducted a heartwarming New for Seniors." Over 100 medical experts
Accompanies Your Growth—Warm Mid-Autumn Year care initiative at two specialized institutions served elderly residents across 7 districts
Festival" charity event to support children with in Beijing. The Company provided daily necessities and nearly 20 neighborhoods promoting
special needs. We delivered festive greetings and educat ional suppl ies to the chi ldren health care knowledge. Eyebright Medical
to kids at the Beijing Huicongshu Rehabilitation demonstrating its commitment to corporate social has made significant contributions.Education Research Institute where leaders responsibility through tangible actions.expressed heartfelt gratitude for our ongoing
support.
62 632024 Environmental Social and Governance Report
Scientific Popularization
During the Reporting Period
Eyebright Accompanies Your Growth series Eye Care Day Series of Science Activities
Eyebright Medical and its subsidiary collaborated
Science Popularization in Schools Eyebright Medical visited Nanshao Middle School with local hospitals to host Eye Care Day activities in
in Changping District Beijing for the "Eyebright
Beijing and Yantai Shandong.Accompanies Your Growth" event. We educated
students and teachers on eye health and myopia
In Beijing we partnered with ophthalmology experts
prevention through lectures and outdoor activities
from the Changping District Hospital to educate
encouraging active participation in eye care and
residents on eye health and conducted vision and
enhancing knowledge to protect their vision.cataract screenings for middle-aged and elderly
individuals providing tailored treatment advice and
health guidance based on their results.Eyebright Yantai collaborated with the Penglai
Back-to-School Science Exploration Day Eyebright Medical in collaboration with the Beijing District Disabled Persons' Federation and local
Drug Administration's Fourth Branch hosted the ophthalmologists to host Eye Care Day activities."Eyebright Accompanies Your Growth—First Lesson We conducted eye health lectures and disease
of School: Together for Eye Health" science open screenings in the community providing residents
day at our headquarters. The event attracted many with convenient and comprehensive health services
children teens and parents. Through engaging right at their doorstep.activities we promoted eye health awareness and
helped kids develop good eye care habits for the
new school year. Staff from the Drug Administration
shared knowledge on medical devices guiding Beijing Cultural Science and Health Outreach Demonstration Event
attendees on safe and healthy usage.Eyebright Medical participated in the Cultural
Science and Health Outreach Event at Xingshou
School in Changping District. We showcased our
innovative technologies in surgical treatment myopia
prevention and vision care allowing local residents
to experience advanced ophthalmic technology
firsthand.Youth Talent Career Experience Day
During the "Penglai Students Explore Hometown"
Exploring Ophthalmic Medical Activities Eyebright Medical launched the theme event event over 30 Penglai students visited Eyebright
"Eyebright Accompanies Your Growth—Exploring the (Yantai). Through immersive visits students gained
Wonders of Vision and Illuminating the Window to the in-depth insights into their hometown's cutting-edge
Soul." High school students from Beijing's Changping advancements and acknowledging the rapid and
District visited our headquarters to explore the transformative progress shaping their hometown.fascinating world of ophthalmic medicine. They Committed to returning for employment and
experienced firsthand how technology safeguards entrepreneurship the students aim to contribute
human visual health. their skills to the modernization of the new port city.
64 652024 Environmental Social and Governance Report
Governance
Eyebright Medical strictly complies with relevant laws
regulations and normative guidelines in its corporate
governance. The Company continuously improves
its corporate structure and standardizes internal
controls and risk management systems protects
rights and interests of shareholders and investors
upholds business ethics pr ior i t izes information
security and privacy and safeguards the Company’s
high-quality development.
66 672024 Environmental Social and Governance Report
Corporate Governance Board Operation
Eyebright Medical continuously establishes a robust management mechanism comprising the " Three
Governance Bodies and Senior Management." The Company has further revised internal control
systems including the Articles of Association Rules of Procedure for the Board of Directors Internal
Eyebright Medical continues to enhance its corporate governance structure and operating mechanisms through Audit Management Regulations and the Operational Guidelines for the Board Audit Committee and has Independence formulated the Work Guidelines for Independent Directors. Independent directors are required to submit
the practice and actively builds a governance system that aligns with the requirement of modern economic the Independence Self-Assessment Report to the Board of Directors annually. The board evaluates the
system and high-quality development. It continuously emphasizes compliance management and strengthen reports and issues a Special Assessment Report ensuring that the independent directors meet regulatory
its legal governance and operations. In strict compliance with applicable laws and regulations the Company requirements on independence thereby ensuring robust and effective corporate governance.rigorously adheres to the principles of transparency and accountability in its information disclosure practices.Our governance practices emphasize the alignment of corporate value creation with investor protection
objectives ensuring equitable treatment of all stakeholders while upholding the sustainable interactions with
the capital markets.The Company is committed to promoting board diversity based on the Company’s development
needs. In selecting board members the Company fully considers various factors such as gender age
Diversity expertise academic level and education background. Drawing upon their diverse professional expertise
and industry-specific knowledge board members deliver informed perspectives and well-founded
recommendations that enhance the Company's governance framework and strategic oversight.Governance Structure
General Meeting of Shareholders
The Company follows the Company Law Securities The board includes four specialized committees—Strategic Committee Audit Committee Nomination
Law and STAR Market Listing Rules of the Shanghai Committee and Compensation and Assessment Committee. These committees operate under Board
Stock Exchange as well as other relevant administrative delegation with defined operational mandates executing governance responsibilities with professional
regulations and normative documents maintaining Specialization rigor and ethical integrity. Members maintain rigorous meeting attendance engage in systematic review
a well-structured internal governance framework Board of of management reports and conduct robust oversight through critical evaluation processes. Their
Supervisors structured advisory input ensures Board deliberations incorporate multidimensional expertise thereby
comprising a General Meeting of Shareholders enhancing decision-making quality and governance efficacy.Board of Directors Supervisory Board and Senior
Management. The board of directors comprises
nine members including six Non-Independent
Directors and three Independent Directors. The Board of Directors
Board is responsible for leading and overseeing Eyebright Medical continues to strengthen the roles of the shareholders' meeting board of directors and
the Company’s business operations strategic board of supervisors to ensure effective decision-making management and oversight. Their collaboration
planning and internal organizational structure promotes scientific efficient and transparent processes for major decisions and compliance safeguarding
and has established the Audit Committee Strategy Effectiveness the Company’s stable development and regulatory compliance. During the reporting period the board of
directors supervisory board and shareholders' meetings strictly adhered to statutory obligations under
Committee Compensat ion and Assessment the Company Law and Securities Law with all convening procedures participant eligibility criteria and
Committee and Nomination Committee. All members voting mechanisms demonstrating full compliance with regulatory requirements.have relevant industry experience professional
knowledge and regularly participate in various types
of training to improve their competencies.During the reporting period
7 board meetings with 47 proposals approved 5 supervisory committee meetings with 36
proposals approved
8 board committees meetings with 40 1 shareholders' meeting with 11 proposals
proposals approved approved
General Manager’s Office
6869
Strategy Committee
Audit Committee
Compensation and
Assessment Committee
Nomination Committee2024 Environmental Social and Governance Report
Information Disclosure
The Company follows STAR Market Listing Rules of
the Shanghai Stock Exchange and other relevant
laws as well as the provisions of its Information
Disclosure Management System to conduct
information disclosure operations. It enhances
effective management of information disclosure and
strengthens its authenticity accuracy completeness
timeliness and compliance. It aims to improve
disclosure quality and protect all shareholders
particularly minority ones receiving the highest A
rating in the Shanghai Stock Exchange (SSE) Annual
Information Disclosure Work Evaluation for two
consecutive years.Investor Relations Management
Investor Communication
The Company prioritizes the concerns of market
participants and strives to build a bridge of trust
to ensure a fair and objective understanding of The Company emphasizes two-way communication During the Reporting Period
its strategy and operations thereby enhancing with institutional investors and analysts through 6
conf idence in i t s fu ture deve lopment . The performance briefings and events such as "Listed Over 2 0 + financial institutions published nearlyCompany has established the Investor Relationship Companies Enter Hong Kong – Investor Exchange” 60 research reports and performance reviewsManagement System which clearly defines the and “Discover New Opportunities in Investing inprinciples organization methods for investor relations China." These efforts aim to enhance its capital assigning ratings such as " B u y " and " Hold ."
activities. Through rigorous execution of this system market image and foster a positive valuation system.the Company strives to build a mutually trusting and
harmonious investor relations framework.Investor Protection
The Company engages with investors through
multiple channels including dedicated investor The Company convenes shareholders' meetings
hotline IR email and the SSE E-Interaction platform lawfully safeguarding shareholders' rights to
providing timely and comprehensive responses information participation inquiry and voting. It
to inquir ies regarding corporate operations actively solicits investor feedback on corporate
management and business development. It also governance and sustainable development initiatives.listens attentively to investor opinions ensures Through initiatives such as the “Financial Educationtheir rights to information accurately conveys Awareness Month” the Company enhances
the Company’s value and strengthens investor investors’ understanding of market rules risks and
confidence. opportunities strengthens risk prevention awareness
and fosters a culture of value-driven and long-term
During the Reporting Period investment.Held 6 Earning Conference Call
70 712024 Environmental Social and Governance Report
Investor Returns Market Capitalization
Management Risk Management and Control
Eyebright Medical places great emphasis on market
value management adhering to the requirements
of the Guidelines for Listed Company Supervision The Company has established a risk management system and continues to improve its internal control system
No.10–Market Value Management the Company shall and adhered to a culture of integrity pragmatism fairness justice and incorruptibility. By systematically
legally and comprehensively utilize diversified market enhancing the ethical competence of all personnel we strive to achieve long-term stable healthy and
value management tools to ensure its investment sustainable development.value rationally reflects its quality.Chairman and controlling shareholder the board
proposed a stock buyback using company funds.Compliance and Internal Related Party Transactions
During the Reporting Period Control Management and Control
In proactive response to the initiative of securities
RMB
regulatory authorities the Company released the 142800 20.04 Million
Shares repurchased Total amount spent The Company places high priority on advancing To ensure fairness impartiality and equitability in
2024 Quality Improvement and Effect Enhancement
internal control and compliance system development. related party transactions and to prevent controlling
Action Plan to protect the investors’ rights and
It has devised a comprehensive framework tailored shareholders actual controllers and directors and
interests and prioritize the investor achievement.to the corporation. A dynamic update mechanism related personnel from harming the interests of the
In March 2025 the Shanghai Stock Exchange Based on their confidence in the Company’s future has been set up to coordinate between compliance Company and minority shareholders the Company
recognized the Company's exemplary practices in development trends and investment value from legal affairs and audit functions to regularly review has formulated the Related Party Transaction
shareholder value creation and investor relations as June to December 2024 certain directors and senior and revise internal policies. Revisions are made Decision-Making System. The Company and its
a demonstration case in several key areas as part of management conducted share purchases through in response to changes in laws regulations and subsidiaries strictly comply with the Company Lawthe SSE’s “Best Practices Handbook for the Special centralized bidding transactions on the Shanghai supervisory policies as well as practical insights the Securities Law and the Articles of AssociationAction on Quality and Returns”. Stock Exchange trading system. gained from daily operations and management to regulate related party transactions ensuring that
practices guaranteeing the timeliness effectiveness no such transactions have harmed the interests of
In 2024 the Company implemented a distribution
During the Reporting Period and applicability of the systems. minority shareholders. The Company follows the
plan. It distributed RMB4.90 (before tax) in cash required review and decision-making procedures.dividends for every 10 shares held and capitalized
45109 The Company emphasizes the operationalization of During deliberations on related-party transaction capital reserves to issue 8 additional shares for every
Total Shares Purchased its compliance governance framework and enhances proposals relevant parties abstained from voting
10 shares held. enterprise-wide compliance awareness through multi- to ensure fairness and reasonableness of such
RMB3.44 Million dimensional measures. It has created a transparent transactions.
2024 Total Amount Purchased platform to share compliance policies and operational
procedures with all employees including those in During the Reporting Period
51.5 subsidiaries ensuring the consistency of policy RMB Million
Total Cash Dividends In line with its development goals and funding needs implementation. Additionally a tiered training system
in October 2024 the Company initiated a simplified has been established to conduct the regular sessions NO insider trading occurred
process to issue shares to specific investors aiming for improving compliance awareness and execution 84.09 Million Shares N O instances of shareholder to raise up to RMB300 million attracting strong capabilities. Moreover the Company has opened
Total Capitalization of Capital Reserves rightsinfringement or corporate asset diversion
interest from both domestic and foreign investors. up feedback channels to encourage employees to
suggest compliance improvements thereby fostering
a participatory culture that supports long-term
healthy development.
72 732024 Environmental Social and Governance Report
Analysis of Public Opinion Anti-Competitive Practices Information Security
In the medical device industry any quality or safety incidents related to the manufacturing distribution or sale Eyebr ight Med ica l p romotes a fa i r market The Company prioritizes information security and
of medical devices are prone to attract widespread media attention. To manage this risk we have established a environment by strictly adhering to the Anti-Unfair privacy protection by enforcing comprehensive
Reputation Management System that addresses reputational risks in strategic planning corporate governance Competition Law the Anti-Monopoly Law of PRC and network and computer management policies and
business operations information disclosure and employee management. This system enhances the ability other relevant regulations to prevent any occurrence building a comprehensive and efficient information
to manage reputational events by promptly identifying assessing monitoring responding to and reporting of unfair competition. The Company requires all system thereby establishing a sound information
reputational risks ensuring timely detection and response. This helps to minimize losses and negative impacts employees to maintain integrity and fairness in security and privacy protection management
on the Company its stakeholders and the industry safeguard the Company’s brand value and corporate image interactions with competitors customers and f ramework . The f ramework i s des igned to
and promote sustainable healthy and stable development. suppliers ensuring truthful product representation. comprehensively safeguard the data security and
confidentiality effectively mitigate information
During the Reporting Period security risks and ensure stable and sustainable During the Reporting Period
operations.N O significant reputation-related issues or media inquiries NO unfair competition lawsuits occurred
Anti-Fraud and Anti-Corruption Measures Reporting Mechanism
Eyebright Medical upholds "Integrity and Practicality" as one of its core values strictly following the laws and
Eyeb r i gh t Med i ca l has i n s t i t u t i ona l i zed a
regulations like the Provisional Regulations on the Prohibition of Commercial Bribery and adheres to high
comprehensive whistleblowing framework aligned
standards of business ethics. It has established a supervision team to prevent commercial bribery and set up a
with global compliance standards. The Company
reporting hotline creating a collaborative anti-bribery oversight mechanism.enforces stringent whistleblower protection protocols
to safeguard identities and reported content
We actively conduct trainings on the business ethics and anti-fraud and the training on the Code of Conduct
through multilayered confidentiality safeguards. All
focusing on professional conduct and anti-bribery and related topics supporting by use case studies. Trainings
submissions via dedicated hotlines secured email or
also reinforce understanding of internal regulations like the Employee Code of Conduct the Gift Acceptance
postal services undergo triaged case management to
Management Policy and Whistleblowing Policy ensuring clear reporting processes and strengthening anti-fraud
ensure impartiality and traceability.defenses.The Company integrates business ethics oversight into daily operations and emphasizes employee integrity Reporting Channels
during audits to prevent and detect fraud risks. Internal reporting channels are kept open and independent Information Security and Privacy Protection
for anonymous tip-offs and investigations are carried out objectively and fairly while strictly maintaining
confidentiality to protect whistleblower rights. （86）10-60745730
Partner Information Security Management
During the Reporting Period
NO contact@ebmedical.comrelated issues were reported
Physical Access Control
NO significant corruption incidents occurred
74 752024 Environmental Social and Governance Report
Appendix GRI Standards Disclosure GRI Standards Disclosure Report Section
Item Number Item Name
General Disclosure
GRI Standards Disclosure GRI Standards Disclosure GRI2：Stakeholder Engagement
Report Section
Item Number Item Name GRI 2-29 Approach to Stakeholder Engagement Stakeholder Communication
General Disclosure GRI 2-30 Collective Bargaining Agreements Employee Development
GRI2：General Disclosures GRI3：Material Topics
GRI 2-1 Organization Detail About the Report GRI 3-1 Process to Determine Material Topics Materiality Assessment
GRI 2-2 Entities Including in the Organization’s Sustainability Reporting About the Report GRI 3-2 List on Material Topics Materiality Assessment
GRI 2-3 Reporting Period Frequency and Contact Point About the Report GRI 3-3 Management on Material Topics Materiality Assessment
GRI 2-4 Restatements of Information / Economic
GRI 2-5 External Assurance Board Statement GRI201：Economic Performance
GRI2：Activities and Workers Topic management disclosures
GRI 2-6 Activities Values Chain and other business Relationships About Us GRI 201-1 Direct Economic Value Generated and Distributed Corporate Governance
GRI 2-7 Employee Employee Development Financial Implications and Other Risks and Opportunities due
GRI 2-8 GRI 201-2 Climate Action Non-employee workers / to Climate Change
GRI2：Governance GRI 201-3 Defined Benefit Plan Obligations and Other Retirement Plans Employee Development
GRI 2-9 Governance Structure and Composition Corporate Governance GRI203：Indirect Economic Impacts
GRI 2-10 Nomination and Selection of the Highest Governance body Corporate Governance Topic management disclosures
GRI 2-11 Chair of the Highest Governance Body Corporate Governance GRI 203-1 Infrastructure Investments and Services Supported Serve The Society
Role of the Highest Governance Body in Overseeing the GRI 203-2 Significant Indirect Economic Impacts Serve The Society
GRI 2-12 Corporate Governance
Management of Impacts
GRI205：Anti-Corruption
GRI 2-13 Delegation of Responsibility forManaging Impacts Corporate Governance Topic management disclosures Risk Management
GRI 2-14 Role of the Highest Governance Body in Sustainability Reporting Board Statement GRI 205-1 Operations Assessed for Risks Related to Corruption /
GRI 2-15 Conflict of Interest Stakeholder Communication
Communication and Training About Anti-Corruption Policies
GRI 205-2 Risk Management
GRI 2-16 Communication of critical concerns Stakeholder Communication and Procedures
GRI 2-17 Collective knowledge of the highest governance body Corporate Governance GRI2016：Anti-Competitive Behavior
GRI 2-18 Evaluation of the performance of the highest governance body Corporate Governance Topic management disclosures Risk Management
GRI 2-19 Remuneration Policies Corporate Governance
GRI 206-1 Legal Actions for Anti-Competitive Behavior Anti-
GRI 2-20 Process to determine remuneration / GRI 206-1 /trust and Monopoly Practices
GRI 2-21 Annual Total Compensation Ratio /
Environmental
GRI2：Strategy Policies and Practices
GRI301：Materials
GRI 2-22 Statement on Sustainable Development Strategy ESG Strategy Planning
Topic management disclosures Risk Management
Pollution Prevention Employee
GRI 2-23 Policy Commitment GRI 301-2 Recycled Input Materials Used /Development Corporate Governance
GRI 301-3 Reclaimed Products and Their Packaging Materials /
GRI 2-24 Embedding Policy Commitments Employee Development
GRI302：Energy
GRI 2-25 Processes to Remediate Negative Impacts Risk Management
Topic management disclosures Risk Management
GRI 2-26 Mechanisms for Seeking Advice and Raising Concerns Stakeholder Communication
GRI 302-1 Energy Consumption within the Organization Resources Management
GRI 2-27 Compliance with Laws and Regulations Risk Management
GRI 302-3 Energy Intensity Resources Management
GRI 2-28 Membership Associations Collaborative Advancement in the Industry
GRI 302-4 Reduction of Energy Consumption Resources Management
GRI 302-5 Reductions in Energy Requirements of Products and Services Resources Management
76 772024 Environmental Social and Governance Report
GRI Standards Disclosure GRI Standards Disclosure GRI Standards Disclosure GRI Standards Disclosure
Report Section Report Section
Item Number Item Name Item Number Item Name
Environmental Social
GRI303：Water and Effluents GRI403：Occupational Health and Safety
GRI 303-1 Interactions with Water as a Shared Resource Resources Management Topic management disclosures Employee Development
GRI 303-2 Management of Water Discharge Related impacts Resources Management GRI 403-3 Occupational Health Services Employee Development
GRI 303-3 Water Withdrawal Resources Management Worker Participation Consultation and Communication on
GRI 403-4 Employee Development
Occupational Health and Safety
GRI 303-4 Water Discharge Pollution Prevention
GRI 303-5 Water Consumption Resources Management GRI 403-5 Worker Training on Occupational Health and Safety Employee Development
GRI305: Emissions GRI 403-6 Promotion of Worker Health Employee Development
Topic management disclosures Climate Action Prevention and Mitigation of Occupational Health and safety
GRI 403-7 Employee Development
GRI 305-1 Direct (Scope 1) GHG Emissions / Impacts Directly Linked by Business Relationships
GRI 305-2 Energy Indirect (Scope 2) GHG Emissions Climate Action Workers Covered by an Occupational Health and Safety
GRI 403-8 Employee Development
Management System
GRI 305-4 Other Indirect (Scope 3) GHG Emissions Climate Action
Nitrogen Oxides (NOx) Sulfur Oxides (SOx) and Other GRI 403-9 Work-Related Injuries Employee Development
GRI 305-7 /
Significant Air Emissions GRI 403-10 Work-Related Ill Health Employee Development
GRI306：Waste GRI404:Training and Education
GRI 306-1 Waste Generation and Significant Waste-Related Impacts Pollution Prevention Topic management disclosures Employee Development
GRI 306-2 Management of Significant Waste Related Impacts Pollution Prevention GRI 404-1 Average Hours of Training per Year per Employee Employee Development
GRI 306-3 Waste Generated Pollution Prevention
Programs for Upgrading Employee Skills and Transition
GRI 404-2 Employee Development
GRI 306-4 Waste Diverted from Disposal / Assistance Programs
GRI 306-5 Waste Directed to Disposal / Percentage of Employees Receiving Regular Performance and
GRI 404-3 Employee Development
GRI308：Supplier Environmental Assessment Career Development Reviews
Topic management disclosures Product Responsities GRI405:Diversity and Equal Opportunity
New Suppliers that were Screened Using Environmental Topic management disclosures Employee Development
GRI 308-1
Criteria /
Employee Development
GRI 405-1 Diversity of Governance Bodies and Employees
Corporate governance
Negative Environmental Impacts in the Supply Chain and
GRI 308-2
Actions Taken / GRI 405-2 Ratio of Basic Salary and Remuneration of Women to Men Employee Development
Social GRI406:Non-Discrimination
GRI401：Employment Topic management disclosures Employee Development
GRI 406-1 Incidents of Discrimination and Corrective Actions Taken Employee Development
Topic management disclosures Employee Development
GRI407 :Freedom of Association and Collective Bargaining
GRI 401-1 New Employee Hires and Employee Turnover Employee Development
Topic management disclosures Employee Development
Benefits Provided to Full-Time Employees that are not Provided
GRI 401-2 Employee Development
to Temporary or Parttime Employees
GRI 407-1 Operations and Suppliers in which the right to freedom of /
Association and Collective Bargaining may be at Risk
GRI402：Labor/Management Relations
GRI408:Child Labor
Topic management disclosures Employee Development
GRI403：Occupational Health and Safety Topic management disclosures Employee Development
Topic management disclosures Employee Development Operations and Suppliers at Significant risk for Incidents of GRI 408-1 /
Child Labor
GRI 403-1 Occupational Health and Safety Management System Employee Development
Hazard Identification Risk Assessment and Incident
GRI 403-2 Employee Development
Investigation
78 792024 Environmental Social and Governance Report
GRI Standards Disclosure GRI Standards Disclosure
Report Section
Item Number Item Name
Social
GRI409：Forced or Compulsory Labor
Operations and Suppliers at Significant risk for Incidents of
GRI 409-1 /Forced or Compulsory Labor
GRI413：Local Community
Topic management disclosures Serve The Society
Operations with Local Community Engagement Impact
GRI 413-1 Serve The Society
Assessments and Development Programs
Operations with Significant Actual and Potential Negative
GRI 413-2 /
Impacts on Local Communities
GRI414：Supplier Social Assessment
Topic management disclosures Product Responsibility
GRI 414-1 New Suppliers that were Screened using Social Criteria Product Responsibility
GRI 414-2 Negative Social Impacts in the Supply Chain and Actions Taken /
GRI416：Customer Health and Safety
Topic management disclosures Product Responsibility
Assessment of the Health and Safety Impacts of Product and
GRI 416-1 Product Responsibility
Service Categories
Incidents of Non-Compliance Concerning the Health and Safety
GRI 416-2 /
Impacts of Products and Services
GRI417：Marketing and Labeling
Topic management disclosures Product Responsibility
Requirements for Product and Service Information and
GRI 417-1 Product Responsibility
Labeling
Incidents of Non-Compliance Concerning Product and Service
GRI 417-2 /
Information and Labeling
Incidents of Non-Compliance Concerning Marketing
GRI 417-3 /
Communications
GRI418：Customer Privacy
Topic management disclosures Product Responsibility
Substantiated Complaints Concerning Breaches of Customer
GRI 418-1 /
Privacy and Losses of Customer Data
80
沪公网安备31011802005267号
